Triochem Products Ltd. engaged in the manufacturing and export of pharmaceuticals, active pharmaceutical ingredient, and chemical products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2006-05-10. The firm operates in the chemical and pharmaceuticals segment. The Company’s product range includes iodine compounds, citrates and piperazine salts. The firm operates in two geographic segments: Within India, which includes sales to customers located within India, and Outside India, which includes sales to customers located outside India. The firm's markets include Europe (Germany, France, the Netherlands, and the United Kingdom), America (the United States, Brazil, Mexico, and Guatemala) and Southeast Asia (Korea, Indonesia, Taiwan, and Australia).
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.
26 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.